UNSPSC 51171857: Fludorex

This classification denotes an antiemetic agent and anorexiant with the molecular formula C11H14F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 346FQP00BI, chemically known as benzeneethanamine, beta-methoxy-n-methyl-3-(trifluoromethyl)- but generally known as fludorex, which bears US NIH Compound Identifier 27139. European Medicines Agency schedules Fludorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07682MIG. The term FLUDOREX is an International Non-Proprietary Name.

UNSPSC 51171857 Fludorex, a Commodity code, covers drug testing products and specimen collection supplies that state and local agencies procure for offender monitoring, employee wellness programs, and public health initiatives. The code encompasses immunoassay screening reagents, confirmation testing supplies (LC/MS/MS or GC/MS), alternative specimen collection media (oral fluid, hair), and associated laboratory materials required to conduct drug testing at scale. State and local issuing bodies soliciting under this code include county criminal justice departments, state health and human services commissions, and multistate cooperative purchasing alliances. Recent activity shows county corrections and supervision departments are primary buyers of specimen collection and drug testing services bundled with lab operations, while state health agencies and cooperative purchasing organizations are sourcing generic pharmaceuticals and OTC products through broader supply agreements that may include testing-related materials.

Texas dominates recent activity. Collin County Community Supervision and Corrections Department issued RFP 2026-327 on July 9, 2026, due July 23, 2026, seeking offender specimen collection and drug testing services across two sites in Plano and McKinney, with approximately 25,031 annual tests (five-panel and six-panel screens plus ancillary testing) at an estimated contract value of $600,000 over two years with three optional one-year renewal periods. Vendors must maintain lab certification from SAMHSA, TX DPS, or CAP and submit pricing per-test basis with three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives). The Texas Health and Human Services Commission issued RFI HHS0017013 on March 27, 2026, due April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs, though this inquiry does not reflect active procurement of fludorex-specific testing supplies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, with awarded vendors effective July 1, 2026. Recent activity is sparse and geographically concentrated; the Collin County RFP represents the most directly relevant current opportunity for fludorex and specimen collection products under this code.